Alain Bitton

27.3k total citations · 1 hit paper
203 papers, 7.1k citations indexed

About

Alain Bitton is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Alain Bitton has authored 203 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Genetics, 108 papers in Epidemiology and 71 papers in Surgery. Recurrent topics in Alain Bitton's work include Inflammatory Bowel Disease (145 papers), Microscopic Colitis (86 papers) and Helicobacter pylori-related gastroenterology studies (22 papers). Alain Bitton is often cited by papers focused on Inflammatory Bowel Disease (145 papers), Microscopic Colitis (86 papers) and Helicobacter pylori-related gastroenterology studies (22 papers). Alain Bitton collaborates with scholars based in Canada, United States and Hungary. Alain Bitton's co-authors include Waqqas Afif, Gary Wild, Talat Bessissow, Ernest G. Seidman, Çharles N. Bernstein, Brian G. Feagan, Albert Cohen, Maida Sewitch, Paul Brassard and Geoffrey C. Nguyen and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Alain Bitton

188 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

2015 311 citations Geoffrey C. Nguyen, Jennifer Jones et al. Gastroenterology profile →

Peers

Countries citing papers authored by Alain Bitton

Since Specialization

Citations

This map shows the geographic impact of Alain Bitton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Bitton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Bitton more than expected).

Fields of papers citing papers by Alain Bitton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Bitton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Bitton. The network helps show where Alain Bitton may publish in the future.

Co-authorship network of co-authors of Alain Bitton

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Bitton. A scholar is included among the top collaborators of Alain Bitton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Bitton. Alain Bitton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes 2025 ·Annals of Internal Medicine ·Yunha Noh, (unknown), Oriana Hoi Yun Yu, Alain Bitton, Laurent Azoulay	3
2	Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study 2024 ·Inflammatory Bowel Diseases ·Çharles N. Bernstein, Remo Panaccione, Zoann Nugent, Deborah A. Marshall, Gilaad G. Kaplan, Stephen Vanner, Levinus A. Dieleman, Lesley A. Graff, Anthony Otley, Jennifer Jones, Michelle Buresi, Sanjay K. Murthy, Mark Borgaonkar, Brian Bressler, Alain Bitton, Kenneth Croitoru, Sacha Sidani, Aida Fernandes, Paul Moayyedi	1
3	P716 Efficacy and safety of upadacitinib during induction in Crohn’s disease: Real-world experience 2024 ·Journal of Crohn s and Colitis ·(unknown), (unknown), (unknown), Waqqas Afif, Alain Bitton, Gary Wild, Neeraj Narula, Péter L. Lakatos, Talat Bessissow	1
4	Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study 2023 ·The Turkish Journal of Gastroenterology ·Panu Wetwittayakhlang, Christine Verdon, Michael Starr, (unknown), Petra A. Golovics, Talat Bessissow, Waqqas Afif, Gary Wild, Alain Bitton, Péter L. Lakatos	1
5	Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study 2023 ·Digestive and Liver Disease ·Panu Wetwittayakhlang, (unknown), (unknown), (unknown), (unknown), Waqqas Afif, Gary Wild, Alain Bitton, Talat Bessissow, Péter L. Lakatos	10
6	A183 VARIATION IN HEALTH SERVICES UTILIZATION AND RISK OF SURGERY ACROSS CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A MULTIPROVINCE COHORT STUDY 2023 ·Journal of the Canadian Association of Gastroenterology ·(unknown), H.B. Singh, Alain Bitton, Gilaad G. Kaplan, Matthew Carroll, Anthony Otley, Thérèse A. Stukel, (unknown), A M Griffiths, David R. Mack, Kevan Jacobson, (unknown), Laura E. Targownik, Wael El‐Matary, (unknown), Eric I. Benchimol	0
7	A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS 2023 ·Journal of the Canadian Association of Gastroenterology ·Stephanie Coward, Eric I. Benchimol, C N Bernstein, J. Antonio Aviña‐Zubieta, Alain Bitton, Lindsay Hracs, J. B. Jones, (unknown), L. Lu, Sanjay K. Murthy, Zoann Nugent, Anthony Otley, (unknown), Juan Nicolás Peña-Sánchez, H.B. Singh, Laura E. Targownik, Joseph W. Windsor, Gilaad G. Kaplan	0
8	The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary 2023 ·Journal of the Canadian Association of Gastroenterology ·Joseph W. Windsor, M Ellen Kuenzig, Sanjay K. Murthy, Alain Bitton, Çharles N. Bernstein, Jennifer Jones, Kate Lee, Laura E. Targownik, Juan Nicolás Peña-Sánchez, Noelle Rohatinsky, (unknown), James Im, (unknown), (unknown), Quinn Goddard, Julia Gorospe, Eric I. Benchimol, Gilaad G. Kaplan	20
9	Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study 2023 ·Inflammatory Bowel Diseases ·Michael Buie, Stephanie Coward, Abdel Aziz Shaheen, Jayna Holroyd‐Leduc, Lindsay Hracs, Christopher Ma, (unknown), Eric I. Benchimol, Çharles N. Bernstein, Alain Bitton, Anthony Otley, Jennifer Jones, Sanjay K. Murthy, M Ellen Kuenzig, Juan Nicolás Peña-Sánchez, Laura E. Targownik, Harminder Singh, Antonio Aviña-Zubieta, Gilaad G. Kaplan	6
10	Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases 2023 ·Crohn s & Colitis 360 ·(unknown), (unknown), (unknown), Sophie Restellini, Alain Bitton, Gary Wild, Waqqas Afif, Péter L. Lakatos, Talat Bessissow, Giada Sebastiani	4
11	961 TEMPORAL TRENDS AND RELATIVE RISKS OF INTESTINAL AND EXTRAINTESTINAL CANCERS IN PERSONS WITH INFLAMMATORY BOWEL DISEASES: A POPULATION-BASED STUDY FROM A LARGE CANADIAN PROVINCE 2023 ·Gastroenterology ·Sanjay K. Murthy, Gilaad G. Kaplan, M Ellen Kuenzig, Stephanie Coward, Eric I. Benchimol, Michael Pugliese, Monica Taljaard, Çharles N. Bernstein, Laura E. Targownik, Geoffrey C. Nguyen, Anthony Otley, Jennifer L. Jones, Alain Bitton, Antonio Aviña-Zubieta, Harminder Singh	1
12	P364 Patient reported outcomes, partial MAYO score and SCCAI are equally accurate in predicting mucosal healing in UC: final results form a prospective study 2021 ·Journal of Crohn s and Colitis ·Petra A. Golovics, Lóránt Gönczi, (unknown), Christine Verdon, Sheetal Pundir, Waqqas Afif, Gary Wild, Alain Bitton, Talat Bessissow, Péter L. Lakatos	0
13	Clinical Outcomes of COVID‐19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease 2021 ·Canadian Journal of Gastroenterology and Hepatology ·Panu Wetwittayakhlang, (unknown), Petra A. Golovics, (unknown), Talat Bessissow, Alain Bitton, Waqqas Afif, Gary Wild, Péter L. Lakatos	17
14	Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures 2019 ·BMC Gastroenterology ·(unknown), Sophie Veilleux, Alain Bitton, Rita Kohen, Luc Vachon, (unknown), John D. Rioux	25
15	Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies 2017 ·Digestive and Liver Disease ·Lóránt Gönczi, Zsuzsanna Kürti, Petra A. Golovics, Barbara D. Lovász, (unknown), (unknown), (unknown), (unknown), Ákos Iliás, (unknown), K Gecse, (unknown), Waqqas Afif, Alain Bitton, Zsuzsanna Végh, Péter L. Lakatos	10
16	Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial 2015 ·The Lancet ·Reena Khanna, Brian Bressler, Barrett G. Levesque, Guangyong Zou, Larry Stitt, Gordon R. Greenberg, Remo Panaccione, Alain Bitton, Pierre Paré, Séverine Vermeire, Geert D’Haens, Donald MacIntosh, William J. Sandborn, Allan Donner, Margaret K. Vandervoort, (unknown), Brian G. Feagan	302
17	Qualitative Study of Physician Perspectives on Classifying Screening and Nonscreening Colonoscopy using Administrative Health Data: Adding Practice Does Not Make Perfect 2012 ·SHILAP Revista de lepidopterología ·Maida Sewitch, Robert J. Hilsden, Lawrence Joseph, Linda Rabeneck, Lawrence Paszat, Alain Bitton, (unknown)	4
18	Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn Disease 2009 ·Journal of Biological Chemistry ·Tiantian Wang, (unknown), David Laperrière, (unknown), Hafid Soualhine, Luz E. Tavera-Mendoza, Serge Dionne, Marc J. Servant, Alain Bitton, Ernest G. Seidman, Sylvie Mader, Marcel A. Behr, John H. White	299
19	Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis 2004 ·The American Journal of Medicine ·Samy Suissa, Pierre Ernst, Marie Hudson, Alain Bitton, Abbas Kezouh	44
20	Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial 2002 ·Gastroenterology ·A. Hillary Steinhart, Brian G. Feagan, Cindy J. Wong, Margaret K. Vandervoort, (unknown), Kenneth Croitoru, Ernest G. Seidman, Desmond Leddin, Alain Bitton, Éric Drouin, Albert Cohen, Gordon R. Greenberg	157

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact